Abbott (ABT) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • Thursday
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?Zacks Investment Research • 11/29/23
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 11/28/23
Abbott (ABT) Up 5.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/17/23
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 11/15/23
Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart PumpPRNewsWire • 11/13/23
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.Market Watch • 11/10/23
Wall Street Analysts See a 25.28% Upside in Abbott (ABT): Can the Stock Really Move This High?Zacks Investment Research • 11/09/23
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in PopularityThe Motley Fool • 11/08/23
Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing DiabetesPRNewsWire • 11/08/23
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to KnowZacks Investment Research • 11/03/23